Lovastatin Tablet
Product Images NDC 43063-548

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 43063-548). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063548 Label (43063548)

Lovastatin 40 mg Tablets USP prescription drug label from PD-Rx Pharmaceuticals, Inc. The label indicates each tablet contains 40 mg of lovastatin, with a total package count of 90 tablets. The label includes storage instructions, manufacturer details (Carlsbad Technology, Inc.), and standard warnings.*

FDA Label Image

Structural Formula (Lov00 0004 01)

Chemical structure diagram of lovastatin, showing its molecular framework with multiple rings, hydroxyl groups, and side chains characteristic of the compound.*

FDA Label Image

Table I (Lov00 0004 02)

A data table titled 'The Effect of Other Drugs on Lovastatin Exposure When Both Were Co-administered' showing interactions between lovastatin and various drugs or grapefruit juice. It includes columns for number of subjects, dosing of coadministered substance, lovastatin dosage, and AUC ratios comparing lovastatin exposure with and without coadministration.*

FDA Label Image

Figure 1 (Lov00 0004 03)

A Kaplan-Meier curve graph titled 'Acute Major Coronary Events (Primary Endpoint)' showing the proportion of participants without event over six years of follow-up. The graph compares Lovastatin versus placebo groups, indicating a 37% risk reduction for Lovastatin with statistical significance (p < 0.001).*

FDA Label Image

Table Vii (Lov00 0005 04)

A data table titled 'Table VII Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis' listing interacting agents such as CYP3A4 inhibitors, HIV protease inhibitors, and others, with corresponding prescribing recommendations related to lovastatin dosage limits and contraindications, including avoidance of grapefruit juice.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.